Dr. Miele Cosmed Group S.A.

DB:9PU Stock Report

Market Cap: €111.7m

Dr. Miele Cosmed Group Past Earnings Performance

Past criteria checks 5/6

Dr. Miele Cosmed Group has been growing earnings at an average annual rate of 15.3%, while the Personal Products industry saw earnings growing at 3.2% annually. Revenues have been growing at an average rate of 8.4% per year. Dr. Miele Cosmed Group's return on equity is 14.1%, and it has net margins of 7.4%.

Key information

15.3%

Earnings growth rate

15.3%

EPS growth rate

Personal Products Industry Growth8.7%
Revenue growth rate8.4%
Return on equity14.1%
Net Margin7.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dr. Miele Cosmed Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9PU Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24483361230
30 Jun 24469321190
31 Mar 24454271130
31 Dec 23444221050
30 Sep 23433111020
30 Jun 234265990
31 Mar 234130960
31 Dec 22397-2940
30 Sep 223864940
30 Jun 223635960
31 Mar 223527950
31 Dec 2135212950
30 Sep 2135521920
30 Jun 2135823850
31 Mar 2136530850
31 Dec 2036529850
30 Sep 2034320810
30 Jun 2033715810
31 Mar 203237790
31 Dec 193103760
30 Sep 19313-2750
30 Jun 19308-4730
31 Mar 19303-6710
31 Dec 18301-7690
30 Sep 18309-72760
30 Jun 18307-71750
31 Mar 18301-78760
31 Dec 17306-79780
30 Sep 17295-20730
30 Jun 17299-20530
31 Mar 17311-10700
31 Dec 16313-6720
30 Sep 162933640
30 Jun 162715760
31 Mar 162484510
31 Dec 152274400
30 Sep 152246370
30 Jun 152067330
31 Mar 151926300
31 Dec 141737270
30 Sep 141618240
30 Jun 141568230
31 Mar 141519210

Quality Earnings: 9PU has high quality earnings.

Growing Profit Margin: 9PU's current net profit margins (7.4%) are higher than last year (2.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9PU has become profitable over the past 5 years, growing earnings by 15.3% per year.

Accelerating Growth: 9PU's earnings growth over the past year (238.1%) exceeds its 5-year average (15.3% per year).

Earnings vs Industry: 9PU earnings growth over the past year (238.1%) exceeded the Personal Products industry 10.8%.


Return on Equity

High ROE: 9PU's Return on Equity (14.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 09:38
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Miele Cosmed Group S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution